BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/7/2017 11:41:16 AM | Browse: 1893 | Download: 3121
Publication Name World Journal of Gastroenterology
Manuscript ID 32488
Country Netherlands
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Retrospective Cohort Study
Article Title Management and outcome of hepatocellular adenoma with massive bleeding at presentation
Manuscript Source Unsolicited Manuscript
All Author List Anne J Klompenhouwer, Robert A de Man, Maarten GJ Thomeer and Jan NM IJzermans
Funding Agency and Grant Number
Corresponding Author Jan NM IJzermans, MD, PhD, Professor, Department of Surgery, Erasmus MC, Rotterdam 3000 CA, the Netherlands. j.ijzermans@erasmusmc.nl
Key Words Hepatocellular adenoma; Management; Bleeding; Outcome; Hemorrhage
Core Tip As massive bleeding due to ruptured hepatocellular adenoma (HCA) is rare, we present a unique series of 23 consecutive patients. To our knowledge, this is the first study to assess the outcome and sequelae of the massive bleeding complication, including risk of rebleeding and need for elective tumor resection. In our series, risk of rebleeding was 4.3% and most HCAs regressed spontaneously. No long-term complications were documented. These cases suggest that a wait-and-watch policy may be legitimate and secondary (elective) treatment may only be considered for persistent HCA > 5 cm after follow-up and/or for patients with desire for future pregnancy.
Publish Date 2017-07-07 11:41
Citation Klompenhouwer AJ, de Man RA, Thomeer MGJ, Ijzermans JNM. Management and outcome of hepatocellular adenoma with massive bleeding at presentation. World J Gastroenterol 2017; 23(25): 4579-4586
URL http://www.wjgnet.com/1007-9327/full/v23/i25/4579.htm
DOI http://dx.doi.org/10.3748/wjg.v23.i25.4579
Full Article (PDF) WJG-23-4579.pdf
Full Article (Word) WJG-23-4579.doc